Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIV-positive Patients Under Tenofovir, Emtricitabine and Efavirenz Therapy Switching From a Two-pill Regimen to a Single Pill Regimen: Patients'Opinion Survey

NCT01322932 is registered in ClinicalTrials.gov with Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland as lead sponsor.

NCT NCT01322932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIV-positive Patients Under Tenofovir, Emtricitabine and Efavirenz Therapy Switching From a Two-pill Regimen to a Single Pill Regimen: Patients'Opinion Survey
Lead sponsor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
February 29, 2012
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection